VeraDermics
A medical dermatology company advancing first-in-class therapeutics that address real-world patient needs in under-innovated dermatology markets.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $75.0m | Series B | |
| Total Funding | 000k | ||
Related Content
VeraDermics is a pioneering company in the dermatology sector, specializing in the development of innovative and less painful treatments for skin conditions, particularly warts. The company leverages the clinical expertise of its team of board-certified dermatologists to identify significant unmet needs in dermatological care and develop targeted solutions. VeraDermics primarily serves patients suffering from common skin conditions, with a special focus on children who require less invasive and more comfortable treatment options. Operating within the pharmaceutical and healthcare markets, the company employs a research-driven business model, investing heavily in clinical trials and product development. Revenue is generated through the commercialization of their proprietary treatments, which are designed to be more effective and less painful than existing options. The company has successfully raised $20.7 million to advance its mission, underscoring its potential for growth and innovation in the dermatology field.
Keywords: dermatology, wart treatment, pediatric care, clinical trials, pharmaceutical innovation, painless solutions, skin conditions, healthcare, research-driven, proprietary treatments.